Clinical Trial Update: Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Alfuzosin to placebo and Tamsulosin in Japanese men with benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Hyperplasia | Phase 3 | Status: COMPLETED